The ratio between the anti-angiogenic factor sFlt-1 and pro-angiogenic PlGF has been shown to be elevated in women with diagnosed preeclampsia and markedly elevated before clinical onset[11, 13–16]. This evidence concerns the gene PGF and preeclampsia.